EU Exclusivity Review: Commission To Assess Impact On 'Skyrocketing' Drug Prices
This article was originally published in The Pink Sheet Daily
Executive Summary
Analysis will consider effect of incentives such as data exclusivity and supplementary protection certificates on drug prices, availability and access to medicines; European health ministers also pledge cooperation rein in what they see as the very high prices of some medicines.